|Bid||74.40 x 800|
|Ask||74.43 x 900|
|Day's range||74.12 - 75.54|
|52-week range||62.43 - 84.49|
|PE ratio (TTM)||28.15|
|Earnings date||1 Aug 2018 - 6 Aug 2018|
|Forward dividend & yield||0.28 (0.37%)|
|1y target est||82.85|
PerkinElmer Inc (NYSE:PKI), a life sciences company based in United States, saw significant share price volatility over the past couple of months on the NYSE, rising to the highs ofRead More...
NEW YORK, May 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cognex ...
Solid prospects in PerkinElmer's (PKI) DAS segment are the key drivers of Q1. Strength in life sciences end markets, informatics profile and OneSource have given the top line a boost.
On a per-share basis, the Waltham, Massachusetts-based company said it had profit of 23 cents. Earnings, adjusted for amortization costs and non-recurring costs, were 63 cents per share. The results topped ...
STERIS' (STE) string of six buyouts in fiscal 2018 keeps us upbeat about the stock. The same is expected to strengthen its Healthcare Specialty Services and Applied Sterilization Technologies arms.
Davita's kidney care unit is gaining prominence worldwide. However, the company is grappling with labor-union woes in California and Ohio.
NEW DELHI--(BUSINESSWIRE)-- The Biotechnology Industry Research Assistance Council (BIRAC) celebrated its 6th Foundation Day on Tuesday in New Delhi. The event, aptly themed ‘Sustaining Innovation: A Market Driven Pathway’, was presided over by the Hon’ble Minister of State for Science and Technology & Earth Sciences, Dr Harsh Vardhan, Prof. Ashutosh Sharma, Secretary, Department of Biotechnology (DBT) and Dr. Renu Swarup, Senior Advisor, DBT & MD, BIRAC, Government of India, and attended by a large number of dignitaries from the scientific and industry sectors both from within the country and overseas.
Thermo Fisher Scientific (TMO) forges ahead with initiatives to strengthen its hold in the high-potential human identification market.
BioScrip's (BIOS) strategy to specifically focus on core revenue mix hurts overall growth. However, the company's core infusion business remains strong.
Orthofix's (OFIX) latest deal to boost Spine Fixation portfolio and strengthen hold in the high-potential artificial disc market buoys optimism.
The acquisition of Sirtex will fortify Varian Medical's (VAR) footprint in Australia. The transaction is likely to close in late May 2018.
Medtronic, (MDT) presenting favorable results from the studies based on the CoreValve TAVR system might boost the top line, with increased uptake of the product.
Laborie Medical Technologies will buy all of the outstanding shares of Cogentix Medical (CGNT) for a net worth of $239 million.
Illumina (ILMN) successfully broadens base by enriching its portfolio of sequencing products and building strategic partnerships with therapeutic and diagnostic service providers.
IDEXX Laboratories (IDXX) continues to boost investor confidence in strong companion animal business along with attractive global prospects.